medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number S1

<< Back Next >>

Rev Mex Anest 2013; 36 (S1)

Clinical scenarios with the use of alpha 2-agonists (dexmedetomidine)

Frederico C
Full text How to cite this article

Language: Spanish
References: 15
Page: 10-12
PDF size: 86.08 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Afonso J, Reis F. Dexmedetomidina: rol actual en anestesia y cuidados intensivos. Rev Bras Anestesiol. 2012;62(1):118-133.

  2. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the Intensive Care Unit. Anaesthesia. 1999;54:1136-1142.

  3. Hunte JC, Fontana DJ, Hedley IR, et al. Assessment of the role of alpha2-adrenoceptor subtypes in the anticonciceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol. 1997;122:1339-1344.

  4. Jones MEP, Maze M. Can we characterize the central nervous system actions of alpha2-adrenergic agonists? British Journal of Anaesthesia. 2001;86(1):1-3.

  5. Yazbek-karam VG, Aouad M. Perioperative uses of dexmedetomidine. MEJ Anesth. 2006;18(6):1043-1058.

  6. Haselman MA. Dexmedetomidine: a useful adjunct to consider in some high-risk situation. AANA J. 2008;76:335-339.

  7. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.

  8. Daqing MA, Rajakumaraswamy N, Maze M. 2-adrenoceptor agonists: shedding light on neuroprotection? British Medical. 2005;71:77-92.

  9. Koroglu A, Demirbilek S, Teksan H, et al. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth. 2005;94:821-824.

  10. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med. 2003;114:742-752.

  11. Rozet I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol. 2008;21:537-543.

  12. García B, Rodríguez L, Salazar PF, Venegas S. Uso de dexmedetomidina en anestesia total intravenosa (TIVA). Rev Colomb Anestesiol. 2011;39:514-526.

  13. Piccinini L, Andrade DT, Malheiros CA, Montoya W, Guaratini A, Vieira J. Uso de dexmedetomidina en pacientes obesos mórbidos sometidos a gastroplastía: estabilidad cardiovascular y consumo de anestésicos venosos. Estudio retrospectivo. Rev Bras Anestesiol. 2006;56(2):68-73.

  14. Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106:1741-1748.

  15. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fenanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24-28.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2013;36